Literature DB >> 19483521

Periungual desquamation in patients with Kawasaki disease.

Susan Wang1, Brookie M Best, Jane C Burns.   

Abstract

Periungual desquamation is one of the clinical signs included in the Kawasaki disease (KD) case definition that manifests after the acute febrile phase of the illness. This clinical sign is sometimes used to diagnose cases that were initially missed. We conducted a retrospective review to determine the frequency with which periungual desquamation is associated with KD.

Entities:  

Mesh：

Year:  2009        PMID： 19483521      PMCID： PMC2738931          DOI： 10.1097/INF.0b013e3181945984

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  8 in total

1.  Commentary: translation of Dr. Tomisaku Kawasaki's original report of fifty patients in 1967.

Authors:  Jane C Burns
Journal:  Pediatr Infect Dis J       Date:  2002-11       Impact factor: 2.129

2.  Coronary artery dimensions may be misclassified as normal in Kawasaki disease.

Authors:  A de Zorzi; S D Colan; K Gauvreau; A L Baker; R P Sundel; J W Newburger
Journal:  J Pediatr       Date:  1998-08       Impact factor: 4.406

3.  A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.

Authors:  T Kawasaki; F Kosaki; S Okawa; I Shigematsu; H Yanagawa
Journal:  Pediatrics       Date:  1974-09       Impact factor: 7.124

4.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].

Authors:  T Kawasaki
Journal:  Arerugi       Date:  1967-03

5.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Circulation       Date:  2004-10-26       Impact factor: 29.690

6.  National surveillance of Kawasaki disease.

Authors:  D M Morens; L J Anderson; E S Hurwitz
Journal:  Pediatrics       Date:  1980-01       Impact factor: 7.124

7.  Epidemiologic aspects of Kawasaki disease in a Manhattan hospital.

Authors:  F Ichida; N S Fatica; J E O'Loughlin; A A Klein; M S Snyder; A R Levin; K H Ehlers; M L Lesser; M A Engle
Journal:  Pediatrics       Date:  1989-08       Impact factor: 7.124

8.  Epidemiologic pictures of Kawasaki disease in Shanghai from 1998 through 2002.

Authors:  Guo-Ying Huang; Xiao-Jing Ma; Min Huang; Shu-Bao Chen; Mei-Rong Huang; Yong-Hao Gui; Shou-Bao Ning; Tuo-Hong Zhang; Zhong-Dong Du; Hiroshi Yanagawa; Tomisaku Kawasaki
Journal:  J Epidemiol       Date:  2006-01       Impact factor: 3.211
  8 in total
  6 in total

1.  A new scoring system for coronary artery abnormalities in Kawasaki disease.

Authors:  Hui Hui Liu; Wei Xia Chen; Man Man Niu; Qi Jiang; Zhen Qiu; Guo Zhen Fan; Rui Xue Li; Goshgar Mammadov; Yang Fang Wu; Huang Huang Luo; Dong Dong Zhang; Peng Hu
Journal:  Pediatr Res       Date:  2021-09-28       Impact factor: 3.953

2.  Severe desquamation in Kawasaki disease: Is it somehow protective?

Authors:  Jubran Theeb Alqanatish; Amir Babiker
Journal:  Sudan J Paediatr       Date:  2017

3.  Perioperative considerations of kawasaki disease.

Authors:  Lisa To; Stephen T Krazit; Alan D Kaye
Journal:  Ochsner J       Date:  2013

4.  Desquamation in Kawasaki Disease.

Authors:  Ling-Sai Chang; Ken-Pen Weng; Jia-Huei Yan; Wan-Shan Lo; Mindy Ming-Huey Guo; Ying-Hsien Huang; Ho-Chang Kuo
Journal:  Children (Basel)       Date:  2021-04-21

Review 5.  Kawasaki Disease.

Authors:  Christian M Hedrich; Anja Schnabel; Toni Hospach
Journal:  Front Pediatr       Date:  2018-07-10       Impact factor: 3.418

6.  Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemic.

Authors:  Ashraf S Harahsheh; Nagib Dahdah; Jane W Newburger; Michael A Portman; Maryam Piram; Robert Tulloh; Brian W McCrindle; Sarah D de Ferranti; Rolando Cimaz; Dongngan T Truong; Jane C Burns
Journal:  J Pediatr       Date:  2020-05-03       Impact factor: 4.406
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.